NEWS

Neurinnov is very pleased to  announce its implication in the AI-Hand Project, launched on last November 28th.

This EU funded project under the programme HORIZON-EIC-2022-PATHFINDEROPEN-01 will last 42 months and intends to restore hand functions in low tetraplegia through selective neural electrical stimulation.

With our partners, we are collectively committed to the success of AI-HAND, in the hope of bringing a solution to patients.

Learn more about this projet.

We are pleased to announced that Neurinnov contributes to the DREIMS european project under the program HORIZON EIC-2023-TRANSITION.

Il will last 36 months and intends to design and develop a multi-contact neural stimulator based on our selective neural stimulation technology in order to treat spinal cord injury, by combining biomaterials, pharmaceuticals, and electrical stimulation into an innovative therapeutic solution able to promote the closure of the spinal cord gap, with axonal regrowth and glial cell migration across large lesions in rodent and porcine models of spinal cord injury.

You can visit DREIMS' web site at: http://www.dreims-project.eu

We are delighted to announce that we have been awarded a €30K prize in the ‘products or services for the future’ category at the Les Inn'Ovations awards by @AD'OCC, for our implantable neurostimulator, which enables patients with complete tetraplegia to regain upper limb autonomy.

Every year, Les Inn’Ovations award recognizes some of the most innovative projects in the Occitania region of France. The awarding jury was impressed by our active implantable medical device, powered by our remotely controlled ASIC chip, which helps restore the manual grip of patients who have suffered spinal cord injury allowing them to complete everyday tasks, such as eating with a fork or drinking through a straw, giving them greater independence.

Neurinnov has published the positive results of its clinical investigations regarding the restoration of hand control for people with high spinal cord injury in Nature Scientific Reports and Neurotrauma. Results achieved in close partnership with INRIA CAMIN, Center Bouffard-Vercelli USSAP, ORTHOSUD St Jean de Védas, CORTEC and APHP.
Click here to see the Nature Scientific Reports, 2022
Click here to see the video.

Des chercheurs et ingénieurs de l'Inria, associés à la société Neurinnov et des établissements de santé en Occitanie, ont mis au point un dispositif médical capable de restaurer, partiellement, les mouvements de la main chez des patients souffrant d'une paralysie des avant-bras. Les premiers résultats cliniques sont validés par une publication scientifique.

Neurinnov is implied in the FLAG-ERA JTC 2021 Rescue Graph Project, coordinated by Universitat Autonoma de Barcelona. This project addresses a functional stimulation system for rehabilitation of gait and driving neural plasticity after spinal cord injury using graphene-based nerve electrodes.

Neurinnov is pleased to announce that it has completed a €3M Seed round led by IRDI Capital Investissement, UI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity Partners) and SOFILARO. A round of financing that reaches €6M, notably through a BPI Deeptech support.

2019 – Deep Tech label awarded by  BPI Occitanie

2018 – EIT Health Innovation Project. Funding of new, solution-driven idea improving healthcare (Neurinnov is External Project Partner).